HB1779 | Illinois 2021-2022 | INS-BIOMARKER TESTING

Link to Summary Link to Summary

Link to Full Text Link to Full Text

On July 30, 2021 in the House:

Governor Approved
Effective Date January 1, 2022
Public Act . . . . . . . . . 102-0203

On June 23, 2021 in the House:

Sent to the Governor

On May 25, 2021 in the House:

Passed Both Houses

On May 25, 2021 in the Senate:

Third Reading - Passed; 058-000-000

On May 14, 2021 in the Senate:

Second Reading
Placed on Calendar Order of 3rd Reading May 17, 2021

On May 13, 2021 in the Senate:

Do Pass Insurance; 011-000-000
Placed on Calendar Order of 2nd Reading May 14, 2021

On May 4, 2021 in the Senate:

Assigned to Insurance

On April 15, 2021 in the Senate:

Arrive in Senate
Placed on Calendar Order of First Reading
Chief Senate Sponsor Sen. Antonio Muñoz
First Reading
Referred to Assignments

On April 14, 2021 in the House:

Third Reading - Short Debate - Passed 112-000-000

On April 13, 2021 in the House:

Second Reading - Short Debate
Placed on Calendar Order of 3rd Reading - Short Debate

On April 8, 2021 in the House:

Placed on Calendar 2nd Reading - Short Debate

On March 25, 2021 in the House:

House Committee Amendment No. 1 Adopted in Insurance Committee; by Voice Vote
Do Pass as Amended / Short Debate Insurance Committee; 019-000-000

On March 23, 2021 in the House:

House Committee Amendment No. 1 Rules Refers to Insurance Committee

On March 21, 2021 in the House:

House Committee Amendment No. 1 Filed with Clerk by Rep. Mary E. Flowers
House Committee Amendment No. 1 Referred to Rules Committee

On March 9, 2021 in the House:

Assigned to Insurance Committee

On February 17, 2021 in the House:

First Reading
Referred to Rules Committee

On February 16, 2021 in the House:

Filed with the Clerk by Rep. Mary E. Flowers

House Amendment 001

Replaces everything after the enacting clause. Amends the Illinois Insurance Code. Provides that a group or individual policy of accident and health insurance or managed care plan amended, delivered, issued, or renewed on or after January 1, 2022 shall include coverage for biomarker testing. Provides that biomarker testing shall be covered and conducted in an efficient manner to provide the most complete range of results to the patient's health care provider without requiring multiple biopsies, biospecimen samples, or other delays or disruptions in patient care. Provides that biomarker testing must be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when the test is supported by medical and scientific evidence. Provides that when coverage of biomarker testing for the purpose of diagnosis, treatment, or ongoing monitoring of any medical condition is restricted for use by health insurers, nonprofit health service plans, or health maintenance organizations, the patient and prescribing practitioner shall have access to a clear, readily accessible, and convenient processes to request an exception, and the process shall be made readily accessible on the insurer's website. Defines "biomarker" and "biomarker testing". Makes conforming changes in the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, the Limited Health Service Organization Act, the Voluntary Health Services Plans Act, and the Illinois Public Aid Code.